We conducted a survey among Italian HIV specialists to study the utilization of statins and aspirin, administering a questionnaire aimed at investigating their use, the use of guidelines and scores, and the management of interactions. The answers were uniform in the different geographic areas. The majority directly prescribe statins and 43% of them prescribe aspirin. The majority follows guidelines and utilize scores to calculate the CV risk. Our survey demonstrates the commitment and autonomy in prescribing statins and aspirin of Italian physicians. There is a rationale to generate guidelines to overcome the differences and limitations among current recommendations.

Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients : a survey among Italian HIV physicians / P. Maggi, G.V. De Socio, S. Cicalini, M. D'Abbraccio, G. Dettorre, A. Di Biagio, C. Martinelli, G. Nunnari, S. Rusconi, L. Sighinolfi, V. Spagnuolo, N. Squillace. - In: NEW MICROBIOLOGICA. - ISSN 1121-7138. - 40:2(2017 Apr), pp. 139-142.

Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients : a survey among Italian HIV physicians

S. Rusconi;
2017

Abstract

We conducted a survey among Italian HIV specialists to study the utilization of statins and aspirin, administering a questionnaire aimed at investigating their use, the use of guidelines and scores, and the management of interactions. The answers were uniform in the different geographic areas. The majority directly prescribe statins and 43% of them prescribe aspirin. The majority follows guidelines and utilize scores to calculate the CV risk. Our survey demonstrates the commitment and autonomy in prescribing statins and aspirin of Italian physicians. There is a rationale to generate guidelines to overcome the differences and limitations among current recommendations.
Aspirin; Cardiovascular disease; HIV; Statins
Settore MED/17 - Malattie Infettive
apr-2017
http://www.newmicrobiologica.org/PUB/allegati_pdf/2017/2/139.pdf
Article (author)
File in questo prodotto:
File Dimensione Formato  
Survey statine-aspirina, New Microbiologica 2017.pdf

accesso riservato

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 442.75 kB
Formato Adobe PDF
442.75 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
139.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 439.18 kB
Formato Adobe PDF
439.18 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/504086
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
  • OpenAlex ND
social impact